Swedish medical device developer Flow Neuroscience has launched home wearable treatments for adult sleathing patients in the UK. Flow’s headset, in conjunction with the Behavioral Therapy app, provides low levels of continuous direct brain stimulation for the user’s left frontal lobe. According to the company, people diagnosed with depression are usually less neuroactive in this area of the brain, which helps control certain cognitive skills and emotional expression.
By rebalancing this activity, Flow hopes to provide results similar to those of a typical antidepressant with fewer side effects. The initial treatment takes about half an hour, three times a week, for a total of six weeks.
While stimulating, the free app provides videos and advice on depression, as well as techniques for alleviating symptoms, with a focus on sleep, nutrition, fitness and meditation. The headset itself retails for 399 pounds.
“We hope to support the improvement of current standards of care for people with depression by increasing treatment options and empowering patients to manage their symptoms at home using effective non-drug alternatives,” Daniel Mansson, co-founder and CEO of Flow, said in a statement. “
The company says individuals who use Flow therapy should not stop current treatments and do not recommend use their products to pregnant women or people under the age of 18. The company is currently in early negotiations with the NHS to obtain the relevant permits. Flow also plans to begin negotiations with the FDA this year.